Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Lymphoma

  Free Subscription


1 Am J Surg Pathol
4 Blood
1 Bone Marrow Transplant
1 Br J Haematol
1 Curr Treat Options Neurol
1 Eur J Haematol
1 J Am Acad Dermatol
5 Leuk Lymphoma
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Surg Pathol

  1. CHEN Z, Liu W, Zhang W, Ye Y, et al
    Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
    Am J Surg Pathol. 2019 Jul 11. doi: 10.1097/PAS.0000000000001324.
    PubMed     Text format     Abstract available


  2. FRIGAULT MJ, Dietrich J, Martinez-Lage M, Leick M, et al
    Tisagenlecleucel CAR-T Cell Therapy in Secondary CNS Lymphoma.
    Blood. 2019 Jul 18. pii: blood.2019001694. doi: 10.1182/blood.2019001694.
    PubMed     Text format     Abstract available

  3. Brady JL, Binkley MS, Hajj C, et al. Definitive radiotherapy for localized follicular lymphoma staged by (18)F-FDG PET-CT: a collaborative study by ILROG. Blood. 2019;133(3):237-245.
    Blood. 2019;134:331.
    PubMed     Text format    

  4. XU S, Huang Q
    "Double-hit" follicular lymphoma.
    Blood. 2019;134:330.
    PubMed     Text format    

  5. NAYAK L, Batchelor TT
    Is it time to revisit R-CHOP for primary CNS lymphoma?
    Blood. 2019;134:221-222.
    PubMed     Text format    

    Bone Marrow Transplant

  6. HSU YT, Tsai HJ, Chang JS, Li SS, et al
    Stem cell transplantation for T-cell lymphomas in Taiwan.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0116.
    PubMed     Text format     Abstract available

    Br J Haematol

  7. GUIDEZ S, Lacotte-Thierry L, Tomowiak C, Princet I, et al
    Oral CHOP-like chemotherapy in 60-80 years-old patients with diffuse large B-cell lymphoma.
    Br J Haematol. 2019 Jul 15. doi: 10.1111/bjh.16056.
    PubMed     Text format    

    Curr Treat Options Neurol

  8. GARCILAZO-REYES Y, Alentorn A, Duran-Pena A, Hoang-Xuan K, et al
    Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients.
    Curr Treat Options Neurol. 2019;21:39.
    PubMed     Text format     Abstract available

    Eur J Haematol

  9. KNAUF W, Abenhardt W, Mohm J, Rauh J, et al
    Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma - Data from the prospective German Tumour Registry Lymphatic Neoplasms.
    Eur J Haematol. 2019 Jul 17. doi: 10.1111/ejh.13295.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  10. WARE O, Tarabadkar ES, Shustov A, Shinohara MM, et al
    Pralatrexate for refractory or recurrent subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome.
    J Am Acad Dermatol. 2019 Jul 15. pii: S0190-9622(19)32379.
    PubMed     Text format    

    Leuk Lymphoma

  11. LOW SK, Zayan AH, Istanbuly O, Minh Duc NT, et al
    Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study.
    Leuk Lymphoma. 2019 Jul 19:1-11. doi: 10.1080/10428194.2019.1633636.
    PubMed     Text format     Abstract available

  12. YAMAGUCHI J, Chinen Y, Takimoto-Shimomura T, Nagata H, et al
    Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma.
    Leuk Lymphoma. 2019 Jul 18:1-8. doi: 10.1080/10428194.2019.1636982.
    PubMed     Text format     Abstract available

  13. WATANABE J, Natsumeda M, Kanemaru Y, Okada M, et al
    Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.
    Leuk Lymphoma. 2019 Jul 15:1-3. doi: 10.1080/10428194.2019.1639169.
    PubMed     Text format    

  14. KUZICH JA, Hutchison AP, Lim KJC, Smallbone P, et al
    Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia.
    Leuk Lymphoma. 2019 Jul 15:1-9. doi: 10.1080/10428194.2019.1637865.
    PubMed     Text format     Abstract available

  15. FERRARINI I, Rigo A, Zamo A, Vinante F, et al
    Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment.
    Leuk Lymphoma. 2019 Jul 14:1-11. doi: 10.1080/10428194.2019.1636983.
    PubMed     Text format     Abstract available

    Oncol Rep

  16. DOMINGUEZ-GOMEZ G, Cortez-Pedroza D, Chavez-Blanco A, Taja-Chayeb L, et al
    Growth inhibition and transcriptional effects of ribavirin in lymphoma.
    Oncol Rep. 2019 Jul 17. doi: 10.3892/or.2019.7240.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.